Back to Alphabet Inc.

BBOT
3 quarters

Position history for Alphabet Inc.'s holdings in BRIDGEBIO ONCOLOGY THERAPEUT

Alphabet Inc. holds 2.8M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $25.3M as of 2026-Q1. BBOT represents 0.6% of Alphabet Inc.'s portfolio.

Current Value

$25.3M

Current Shares

2.8M

Total Value Change

-$7.4M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
2.8M
0.0%
$25.3M0.6%$9.74
0
2025-Q4
Unchanged
2.8M
0.0%
$35.3M1.4%$12.37
0
2025-Q3
New
2.8M
-
$32.7M1.4%$11.47
67

Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, CITADEL ADVISORS LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used